Institutional Ownership Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE). We have compiled data on the 218 institutions that hold shares in the stock, with a total of 49.9 Million shares, which have been reported (via 13F filing form) to have a value of $448 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
South State Corp
|
May 12, 2025 Q1 2025 |
9
shares
|
$80
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Wolff Wiese Magana LLC
|
Jul 17, 2025 Q2 2025 |
7
shares
|
$62
0.0% of portfolio
|
Q3 2023
Reduced 99.6%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
5
shares
|
$44
0.0% of portfolio
|
Q1 2025
Reduced 50.0%
|
|
|
Org Partners LLC
Roanoke, IN |
Jul 16, 2025 Q2 2025 |
5
shares
|
$44
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Apr 21, 2025 Q1 2025 |
2
shares
|
$17
0.0% of portfolio
|
Q4 2024
Reduced 99.63%
|
|
|
Huntington National Bank
Columbus, OH |
May 14, 2025 Q1 2025 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2024
Reduced 98.97%
|
|
|
First Horizon Advisors, Inc.
|
Apr 28, 2025 Q1 2025 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2022
Reduced 93.33%
|
|
|
Activest Wealth Management
|
May 15, 2025 Q1 2025 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|